Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Hematologic Oncology Update
00:00
CD3×CD20 Bispecifics: Profiles and Practical Toxicity
Matt contrasts epcoritamab, glofitamab, and mosunetuzumab, stressing administration differences and managing CRS/fevers.
Play episode from 08:48
Transcript
